Among the pyrimidine antimetabolites used in oncology, which is the most commonly used agent for colorectal cancer and acts primarily as a thymidylate synthase inhibitor?

Explanation

## Most Common Pyrimidine Antimetabolite in Colorectal Cancer **Key Point:** 5-Fluorouracil (5-FU) is the most widely used pyrimidine antimetabolite for colorectal cancer and exerts its primary cytotoxic effect by inhibiting thymidylate synthase (TS), blocking dTMP synthesis and DNA replication. ### Mechanism of Action of 5-Fluorouracil 1. **Prodrug activation:** 5-FU is converted to fluorodeoxyuridine monophosphate (FdUMP) by thymidine phosphorylase and orotate phosphoribosyltransferase 2. **Thymidylate synthase inhibition:** FdUMP forms a stable ternary complex with thymidylate synthase and 5,10-methylenetetrahydrofolate, blocking the conversion of dUMP to dTMP 3. **DNA synthesis blockade:** Depletion of dTMP prevents DNA synthesis, leading to cell death 4. **RNA effects:** 5-FU metabolites also incorporate into RNA, causing additional cytotoxicity ### Comparison of Pyrimidine Antimetabolites | Agent | Primary Mechanism | Main Indications | Tissue Selectivity | |-------|-------------------|------------------|--------------------| | **5-Fluorouracil** | TS inhibition (dTMP ↓) | Colorectal, gastric, breast, head & neck cancers | Broad spectrum | | Cytarabine | DNA polymerase inhibition | AML, ALL, lymphomas | Bone marrow, CNS | | Gemcitabine | Ribonucleotide reductase inhibition | Pancreatic, lung, bladder cancers | Broad spectrum | | Azathioprine | IMPDH inhibition (purine analog) | Autoimmune diseases, transplant rejection | Lymphocytes | **High-Yield:** 5-FU is often combined with **leucovorin (folinic acid)** to enhance TS inhibition by stabilizing the FdUMP–TS–methylenetetrahydrofolate complex. This combination (5-FU/LV) is the backbone of colorectal cancer chemotherapy regimens (e.g., FOLFOX, FOLFIRI). ### Clinical Pearl: 5-FU Metabolism and Toxicity **Clinical Pearl:** Patients with **dihydropyrimidine dehydrogenase (DPD) deficiency** cannot metabolize 5-FU efficiently and experience severe, potentially fatal toxicity (mucositis, myelosuppression, cardiotoxicity). DPD testing is now recommended before 5-FU administration in many centers. **Mnemonic:** **5-FU = Five-Fluorouracil = Thymidylate synthase inhibitor = Fluoropyrimidine = Most common in colorectal cancer**. [cite:Harrison 21e Ch 100]